Red kidney bean lectin is a potent cholecystokinin releasing stimulus in the rat inducing pancreatic growth

Gut

Volumn 41, Issue 3, 1997, Pages 333-338

  Herzig, K H ^a   Bardocz, S ^c   Grant, G ^c   Nustede, R ^b   Folsch U R ^a   Pusztai, A ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cholecystokinin; Cholecystokinin A receptor antagonist; Intestinal growth; Pancreatic growth; Phytohaemagglutinin

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; DEVAZEPIDE; LACTALBUMIN; LECTIN; PHYTOHEMAGGLUTININ; SOYBEAN TRYPSIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DUODENUM MUCOSA; GASTROINTESTINAL TRACT; GROWTH STIMULATION; HISTOLOGY; HORMONE RELEASE; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 0030782947     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.3.333     Document Type: Article

References (57)

1. Dixon HBF. Defining a lectin. Nature 1981; 292: 192.
2. Etzler ME. Plant lectins: molecular and biological aspects. Annu Rev Plant Physiol 1985; 36: 209-34.
3. Stillmark H. Über Ricin. In: Kobert R, ed. Arbeiten des Pharmkologischen Instituts zu Dorpat. Stuttgart: Enke, 1989: 59-151.
4. Boyd WC, Reguera RM. Studies on the haemagglutinins present in seeds of some representatives of the family leguminosae. J Immunol 1949; 62: 333-9.
5. Nachbar MS, Oppenheim JD. Lectins in the United States diet: a survey of lectins in commonly consumed foods and a review of the literature. Am J Clin Nutr 1980; 33: 2338-45.
6. Peumans WJ, Van Damme ELM. Lectins as plant defense proteins. In: Pusztai A and Bardocz S, eds. Lectins, Biomedical perspectives. London: Taylor and Francis, 1995: 1-22.
7. Liener IE. Nutritional significance of lectins in the diet. In: Liener IE, Sharon N, Goldstein IJ, eds. The lectins, Properties, function and applications in biology and medicine. Orlando, FL: Academic Press, 1986: 527-52.
8. Leavitt RD, Felsted RL, Bachur NR. Biological and biochemical properties of Phaseolus vulgaris isolectins. J Biol Chem 1977; 252: 2967-71.
9. Gabriel C. Erkrankungen durch Bohnenflocken (Phaseolus vulgaris) und Platterbsen (Lathyrus tingitanus L.). Z Lebensm Untersuch Forsch 1950; 90: 191-7.
10. Noah HD, Bender AE, Reaidi GB, Gilbert RJ. Food poisoning from red kidney beans. BMJ 1980; 281: 236-7.
11. King TP, Pusztai A, Grant G, Slater D. Immunogold localization of ingested kidney bean (Phaseolus vulgaris) lectins in epithelial cells of the rat small intestine. Histochem J 1986; 18: 413-20.
12. Bardocz S, Grant G, Ewen SWB, Duguid TJ, Brown DS, Englyst K, Pusztai A. Reversible effect of phytohaemagglutinin on the growth and metabolism of rat gastrointestinal tract. Gut 1995; 37: 353-60.
13. Bardocz S, Grant G, Brown DS, Ewen SWB, Pusztai A. Involvement of polyamines in Phaseolus vulgaris lectin-induced growth of rat pancreas in vivo. Med Sci Res 1989; 17: 309-11.
14. Banwell JG, Howard R, Kabir I, Arian TE, Diamond RH, Abramowsky C. Small intestinal growth caused by feeding red kidney bean phytohemagglutimn lectin to rats. Gastroenterology 1993; 104: 1669-77.
15. Oliveira JTA de, Pusztai A, Grant G. Changes in organs and tissues induced by feeding of purified kidney bean (Phaseolus vulgaris) lectins. Nutr Res 1988; 8: 943-7.
16. Mainz DL, Black O, Webster PO. Hormonal control of pancreatic growth. J Clin Invest 1973; 52: 2300-4.
17. Pusztai A, Watt WB. Isolectins of Phaseolus vulgaris. A comprehensive study of fractionation. Biochim Biophys Acta 1974; 365: 57-71.
18. Pusztai A, Palmer R. Nutritional evaluation of kidney bean (Phaseolus vulgaris): the toxic principle. J Sci Food Agric 1977; 28: 620-3.
19. Pusztai A, Stewart JC, Watt WB. A comprehensive scheme for the isolation of trypsin inhibitors and the agglutinin from soybean seeds. J Agric Food Chem 1991; 39: 862-6.
20. Schachterle GR, Pollack RL. A simplified method for the quantitative assay of small amounts of protein in biological material. Anal Biochem 1973; 51: 654-5.
21. Løvtrup S. Chemical determination of DNA in animal tissues. Acta Biochim Pol 1962; 9: 411-24.
22. Schafmayer A, Werner M, Becker HD. Radioimmunological determination of cholecystokinin in tissue extracts. Digestion 1982; 24: 146-54.
23. Schafmayer A, Nustede R, Pompino A, Köhler H. Vagal influence on cholecystokinin and neurotensin release in conscious dogs. Scand J Gastroenterol 1988; 23: 315-20.
24. Bouras EP, Misukonis MA, Liddle RA. Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells. Am J Physiol 1992; 262: G791-6.
25. Herzig KH, Brunke G, Schön I, Schäffer M, Fölsch UR. Mechanism of Galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission studies in vivo and in vitro. Gut 1993; 34: 1616-21.
26. Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor and alcohol. Gastroenterology 1984; 87: 542-9.
27. 1)-a-D-maltoheptaoside as substrate. J Clin Chem Clin Biochem 1989; 27: 103-13.
28. Pusztai A, Ewen EWB, Grant G, Peumans WJ, Van Damme EJM, Rubio L, et al. Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors. Digestion 1990; 4 (suppl 2): 306-16.
29. King TP, Pusztai A, Clarke EMW. Kidney bean (Phaseolus vulagris) lectin-induced lesions in rat small intestine: 1. Light microscope studies. J Comp Pathol 1980; 90: 585-95.
30. King TP, Pusztai A, Clarke EMW. Kidney bean (Phaseolus vulagris) lectin-induced lesions in rat small intestine: 3. Ultrastructural studies. J Comp Pathol 1982; 92: 357-73.
31. Banwell JG, Howard R, Kabir I, Costerton JW. Bacterial overgrowth by indigenous microflora in the phytohemagglutinin-fed rat. Can J Microbiol 1988; 34: 1009-13.
32. Rattray EAS, Palmer R, Pusztai A. Toxicity of kidney beans (Phaseolus vulgaris L.) to conventional and gnotobiotic rats. J Sci Food Agric 1971; 25: 1035-40.
33. Weinman MD, Allan CH, Trier JS, Hagen SJ. Repair of microvilli in the small intestine after damage with lectins contained in the red kidney bean. Gastroenterology 1989; 97: 1193-204.
34. Bardocz S, Grant G, Pusztai A, Franklin MF, Carvalho A de FFU. The effect of phytohaemagglutinin at different dietary concentrations on the growth, body composition and plasma insulin of the rat. Br J Nutr 1996; 76: 613-26.
35. Schmidt WE, Roy Choudhury A, Siegel EG, Löser C, Conlon JM, Fölsch UR, et al. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Reg Pept 1980; 24: 67-79.
36. Santer R, Leung YK, Alliet P, Lebenthal E, Lee PC. The role of carbohydrate moieties of cholecystokinin receptors in cholecystokinin octapeptide binding: alteration of binding data by specific lectins. Biochim Biophys Acta 1900; 1051: 78-83.
37. Logsdon CD. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol 1986; 251: G487-94.
38. Shulman RJ. Oral insulin increases small intestinal mass and disaccharidase activity in newborn miniature pig. Pediatr Res 1990; 28: 171-5.
39. Ziegler TR, Almahfouz A, Pedrini MT, Smith RJ. A comparison of rat small intestinal insulin and insulin-like growth factor I receptors during fasting and refeeding. Endocrinology 1995; 136: 5148-54.
40. McCormack SA, Johnson LR. Role of polyamines in gastrointestinal mucosa growth. Am J Physiol 1901; 260: G795-806.
41. Morriset J, Benrezzak O. Polyamines and pancreatic growth induced by caerulein. Life Sci 1984; 35: 2471-80.
42. Lóser Chr, Fölsch UR, Sahelijo-Krohn P, Creutzfeldt W. Ornithine decarboxylase and polyamines in cholecystokinin-induced growth in rats: effects of difluoromethyl-ornithine and the CCK receptor antagonist L364,718. Eur J Clin Invest 1989; 19: 448-58.
43. Pusztai A, Grant G, Brown DS, Ewen SWB, Bardocz S. Phaseolus vulgaris lectin induces growth and increases the polyamine content of rat small intestine in vivo. Med Sci Res 1988; 16: 1283-4.
44. Seiler N. Polyamine metabolism. Digestion 1990; 46 (suppl 2): 319-30.
45. Hughes CA, Bates T, Dowling RH. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog. Gastroenterology 1978, 75: 34-41.
46. Weser E, Bell D, Tawil T. Effect of octapeptide-cholecystokinin, secretin and glucagon on intestinal mucosal growth in parenterally nourished rats. Dig Dis Sci 1981; 26: 409-16.
47. 2 on RNA and DNA of gastric and duodenal mucosa. Gastroenterology 1976; 70: 59-65.
48. Balas D, Senegas-Balas F, Pradayrol L, Vaysette J, Bertrand C, Ribet A. Long-term comparative effect of cholecystokinin and gastrin on mouse stomach, antrum, intestine, and exocrine pancreas. Am J Anat 1985; 174: 27-43.
49. Axelson J, Hakanson R, Ihse I, Lilja I, Rehfeld JH, Sundler F. Effects of endogenous and exogenous cholecystokinin and infusion of cholecystokinin-antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand J Gastroenterol 1990; 25: 471-80.
50. Ryder SD, Smith JA, Rhodes EGH, Parker N, Rhodes JM. Proliferative responses of HAT29 and Caco2 human colorectal cancer cells to a panel of lectins. Gastroenterology 1994; 106: 85-93.
51. Ryder SD, Parker N, Ecclestone D, Haqqani MT, Rhodes JM. Peanut lectin stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon polyps. Gastroenterology 1994; 106: 117-24.
52. Liddle RA, Gertz, BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, et al. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK 329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 1989; 84: 1220-5.
53. Niederau C, Heintges T, Rovati L, Strohmeyer G. Effects of loxiglumide on gallbladder emptying in healthy volunteers. Gastroenterology 1989; 96: 1331-6.
54. Corazziari E, Ricci R, Biliotti D, Bonotempo I, de'Medici A, Pallotta N, et al. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without effecting gastric emptying. Dig Dis Sci 1990; 35: 50-4.
55. Schmidt WE, Creutzfeldt, Schleser A, Roy Choudhury A, Nustede R, Höcker M, et al. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 1991; 260: G197-206.
56. Schmidt WE, Creutzfeldt W, Höcker M, Nustede R, Roy Choudhury A, Schleser A, et al. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastroentero-pancreatic hormones. Eur J Clin Invest 1991; 21: 501-11.
57. Green GM, Levan VH, Liddle RA. Interaction of dietary protein and trypsin inhibitor on plasma cholecystokinin and pancreatic growth in rats. In: Friedman M, ed. Nutritional and toxicological significance of enzyme inhibitors in foods. New York: Plenum Press, 1986: 123-32.